{
    "title": "U.S. FDA declines to approve expanded use of Acadia's antipsychotic drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11083315/U-S-FDA-declines-approve-expanded-use-Acadias-antipsychotic-drug.html",
    "date": "2022-08-05",
    "keywords": [
        "drug",
        "psychosis",
        "company",
        "use",
        "acadia",
        "study",
        "pimavanserin",
        "treatment",
        "approval",
        "food",
        "administration",
        "health",
        "regulator",
        "interpretability",
        "decision",
        "month",
        "panel",
        "conclusion",
        "outcome",
        "area",
        "therapy",
        "officer",
        "davis",
        "attempt",
        "april",
        "fda",
        "trial",
        "application",
        "focus",
        "brand",
        "name",
        "nuplazid",
        "indication",
        "disease",
        "year",
        "reporting",
        "roy",
        "akriti",
        "sharma",
        "bengaluru",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}